ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
ID
Institut de Cancérologie de l'Ouest at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Institut de Cancérologie de l'Ouest takes part in 7 sessions at ESMO 2026 in Madrid. Its sessions focus on breast and lung cancer, including treatment decisions and biomarkers. They examine how artificial intelligence tools assess low levels of HER2 in breast cancer and how early PET scans may help assess lung cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
ID Institut de Cancérologie de l'Ouest Saint-Herblain, France | |
Regional comprehensive cancer centre of the French Unicancer network, with sites in Saint-Herblain near Nantes and in Angers, France. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Poster Sat Oct 24 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Comparative evaluation of 7 artificial intelligence (AI) tools for HER2-low and ultralow scoring in breast cancer (BC) Breast cancerBiomarkers & precision oncology Satellite Sun Oct 25 18:38–19:33 Satellite Sun Oct 25 19:48–19:58 Ask the Expert: Panel Discussion and Audience Q&A Breast cancer Poster Mon Oct 26 12:00–12:45 |
Find decision makers at Institut de Cancérologie de l'Ouest
Tell us what you sell and we’ll find the people at Institut de Cancérologie de l'Ouest most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction